Unknown

Dataset Information

0

G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans.


ABSTRACT: OBJECTIVE:Genome-wide association studies have identified several variants within the MTNR1B locus that are associated with fasting plasma glucose (FPG) and type 2 diabetes. We refined the association signal by direct genotyping and examined for associations of the variant displaying the most independent effect on FPG with isolated impaired fasting glycemia (i-IFG), isolated impaired glucose tolerance (i-IGT), type 2 diabetes, and measures of insulin release and peripheral and hepatic insulin sensitivity. RESEARCH DESIGN AND METHODS:We examined European-descent participants in the Inter99 study (n = 5,553), in a sample of young healthy Danes (n = 372), in Danish twins (n = 77 elderly and n = 97 young), in additional Danish type 2 diabetic patients (n = 1,626) and control subjects (n = 505), in the Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study (n = 4,656), in the North Finland Birth Cohort 86 (n = 5,258), and in the Haguenau study (n = 1,461). RESULTS:The MTNR1B intronic variant, rs10830963, carried most of the effect on FPG and showed the strongest association with FPG (combined P = 5.3 x 10(-31)) and type 2 diabetes. The rs10830963 G-allele increased the risk of i-IFG (odds ratio [OR] 1.64, P = 5.5 x 10(-11)) but not i-IGT. The G-allele was associated with a decreased insulin release after oral and intravenous glucose challenges (P < 0.01) but not after injection of tolbutamide. In elderly twins, the G-allele associated with hepatic insulin resistance (P = 0.017). CONCLUSIONS:The G-allele of MTNR1B rs10830963 increases risk of type 2 diabetes through a state of i-IFG and not through i-IGT. The same allele associates with estimates of beta-cell dysfunction and hepatic insulin resistance.

SUBMITTER: Sparso T 

PROVIDER: S-EPMC2682679 | biostudies-literature | 2009 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans.

Sparsø Thomas T   Bonnefond Amélie A   Andersson Ehm E   Bouatia-Naji Nabila N   Holmkvist Johan J   Wegner Lise L   Grarup Niels N   Gjesing Anette P AP   Banasik Karina K   Cavalcanti-Proença Christine C   Marchand Marion M   Vaxillaire Martine M   Charpentier Guillaume G   Jarvelin Marjo-Riitta MR   Tichet Jean J   Balkau Beverley B   Marre Michel M   Lévy-Marchal Claire C   Faerch Kristine K   Borch-Johnsen Knut K   Jørgensen Torben T   Madsbad Sten S   Poulsen Pernille P   Vaag Allan A   Dina Christian C   Hansen Torben T   Pedersen Oluf O   Froguel Philippe P  

Diabetes 20090326 6


<h4>Objective</h4>Genome-wide association studies have identified several variants within the MTNR1B locus that are associated with fasting plasma glucose (FPG) and type 2 diabetes. We refined the association signal by direct genotyping and examined for associations of the variant displaying the most independent effect on FPG with isolated impaired fasting glycemia (i-IFG), isolated impaired glucose tolerance (i-IGT), type 2 diabetes, and measures of insulin release and peripheral and hepatic in  ...[more]

Similar Datasets

| S-EPMC2873324 | biostudies-literature
| S-EPMC6444495 | biostudies-literature
| S-EPMC2874716 | biostudies-literature
| S-EPMC2682768 | biostudies-literature
| S-EPMC2998495 | biostudies-literature
| S-EPMC4414047 | biostudies-literature
| S-EPMC3402276 | biostudies-literature
| S-EPMC2900202 | biostudies-literature
| S-EPMC2646025 | biostudies-literature
| S-EPMC8626567 | biostudies-literature